129 related articles for article (PubMed ID: 11553852)
1. Cell cycle activation of peripheral blood stem and progenitor cells expanded ex vivo with SCF, FLT-3 ligand, TPO, and IL-3 results in accelerated granulocyte recovery in a baboon model of autologous transplantation but G0/G1 and S/G2/M graft cell content does not correlate with transplantability.
Drouet M; Herodin F; Norol F; Mourcin F; Mayol JF
Stem Cells; 2001; 19(5):436-42. PubMed ID: 11553852
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood.
De Bruyn C; Delforge A; Martiat P; Bron D
Stem Cells Dev; 2005 Aug; 14(4):415-24. PubMed ID: 16137231
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo expanded mobilized peripheral blood CD34+ cells accelerate haematological recovery in a baboon model of autologous transplantation.
Norol F; Drouet M; Mathieu J; Debili N; Jouault H; Grenier N; Laplanche A; Vainchenker W; Hérodin F
Br J Haematol; 2000 Apr; 109(1):162-72. PubMed ID: 10848796
[TBL] [Abstract][Full Text] [Related]
4. The reduction of in vitro radiation-induced Fas-related apoptosis in CD34+ progenitor cells by SCF, FLT-3 ligand, TPO, and IL-3 in combination resulted in CD34+ cell proliferation and differentiation.
Drouet M; Mathieu J; Grenier N; Multon E; Sotto JJ; Herodin F
Stem Cells; 1999; 17(5):273-85. PubMed ID: 10527462
[TBL] [Abstract][Full Text] [Related]
5. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.
Traycoff CM; Abboud MR; Laver J; Clapp DW; Srour EF
Exp Hematol; 1994 Dec; 22(13):1264-72. PubMed ID: 7525328
[TBL] [Abstract][Full Text] [Related]
6. Cytokine-induced expansion of human CD34+ stem/progenitor and CD34+CD41+ early megakaryocytic marrow cells cultured on normal osteoblasts.
Ahmed N; Khokher MA; Hassan HT
Stem Cells; 1999; 17(2):92-9. PubMed ID: 10195569
[TBL] [Abstract][Full Text] [Related]
7. Early-acting cytokine-driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post-mitotic offspring with preserved engraftment ability in non-obese diabetic/severe combined immunodeficient mice.
Herrera C; Sánchez J; Torres A; Bellido C; Rueda A; Alvarez MA
Br J Haematol; 2001 Sep; 114(4):920-30. PubMed ID: 11564087
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice.
Gothot A; van der Loo JC; Clapp DW; Srour EF
Blood; 1998 Oct; 92(8):2641-9. PubMed ID: 9763545
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
[TBL] [Abstract][Full Text] [Related]
10. The rate of marrow recovery and extent of donor engraftment following transplantation of ex vivo-expanded bone marrow cells are independently influenced by the cytokines used for expansion.
von Drygalski A; Savatski L; Eastwood D; Klein J; Adamson JW
Stem Cells Dev; 2005 Oct; 14(5):564-75. PubMed ID: 16305341
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG
Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951
[TBL] [Abstract][Full Text] [Related]
12. Optimization of culture conditions to enhance transfection of human CD34+ cells by electroporation.
Wu MH; Smith SL; Danet GH; Lin AM; Williams SF; Liebowitz DN; Dolan ME
Bone Marrow Transplant; 2001 Jun; 27(11):1201-9. PubMed ID: 11551032
[TBL] [Abstract][Full Text] [Related]
13. Osteopetrotic mouse stroma with thrombopoietin, c-kit ligand, and flk-2 ligand supports long-term mobilized CD34+ hematopoiesis in vitro.
Feugier P; Li N; Jo DY; Shieh JH; MacKenzie KL; Lesesve JF; Latger-Cannard V; Bensoussan D; Crystal RG; Rafii S; Stoltz JF; Moore MA
Stem Cells Dev; 2005 Oct; 14(5):505-16. PubMed ID: 16305336
[TBL] [Abstract][Full Text] [Related]
14. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor.
Ueda T; Tsuji K; Yoshino H; Ebihara Y; Yagasaki H; Hisakawa H; Mitsui T; Manabe A; Tanaka R; Kobayashi K; Ito M; Yasukawa K; Nakahata T
J Clin Invest; 2000 Apr; 105(7):1013-21. PubMed ID: 10749580
[TBL] [Abstract][Full Text] [Related]
15. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
16. Engraftment of primates with G-CSF mobilized peripheral blood CD34+ progenitor cells expanded in G-CSF, SCF and MGDF decreases the duration and severity of neutropenia.
Andrews RG; Briddell RA; Hill R; Gough M; McNiece IK
Stem Cells; 1999; 17(4):210-8. PubMed ID: 10437984
[TBL] [Abstract][Full Text] [Related]
17. Decrease in apoptosis and increase in polyploidization of megakaryocytes by stem cell factor during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin.
Kie JH; Yang WI; Lee MK; Kwon TJ; Min YH; Kim HO; Ahn HS; Im SA; Kim HL; Park HY; Ryu KH; Chung WS; Shin MH; Jung YJ; Woo SY; Park HK; Seoh JY
Stem Cells; 2002; 20(1):73-9. PubMed ID: 11796924
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of mouse bone marrow cells with kit ligand, FLT3 ligand, and thrombopoietin leads to efficient retrovirus-mediated gene transfer to stem cells, whereas interleukin 3 and interleukin 11 reduce transduction of short- and long-term repopulating cells.
Wognum AW; Visser TP; Peters K; Bierhuizen MF; Wagemaker G
Hum Gene Ther; 2000 Oct; 11(15):2129-41. PubMed ID: 11044914
[TBL] [Abstract][Full Text] [Related]
19. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
20. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
